CASI PHARMACEUTICALS, INC. Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests
CASI PHARMACEUTICALS, INC. (CASIF) reported Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests of $22.42 million for the 12-month period ending 2023-12-31, per its 20-F filed 2026-05-15.
Financial Statements › Shareholders' Equity
us-gaap:MinorityInterestDecreaseFromRedemptions · last filed 2026-05-15
| Period end | Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests 12 month |
|---|---|
| 2023-12-31 | $22.42M 20-F · filed 2026-05-15 |